TCRX
TScan TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
TCRX vs peer average
18/100
TCRX vs. peer average (F vs. C)
Grade spread
A 1 · B 3 · C 1 · D 1 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
IMA is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $64.36M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
TCRX
TScan Therapeutics
IMA
ImageneBio
Grade
F
C
Momentum
10
58
Value
58
57
Sentiment
-
44
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Mixed
Grade position vs IMA
TCRX / IMA
Grade Position
Below peers
TCRX vs. peer average (F vs. C)
18/100
Momentum
10
IMAValue
58
TCRXSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs TCRX
IMA is the first peer returned for this comparison set.

